Viking Therapeutics Inc (VKTX)
Healthcare
Biotechnology
32.60 $
+2.7%
vs. previous close
Closing price · As of: 3. Aug 2026
Viking Therapeutics Inc (VKTX) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Operating Cash Flow" came in at -125 million USD. Tick rows to compare them in a chart.
All figures in millions of USD.
| Tick rows to compare them in a chart (up to 4) | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -20 | -18 | -6.1 | -29 | -22 | -31 | -52 | -47 | -94 | -85 | -114 | -125 | -418 | |
| 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | -5.6 | 0.1 | 0.1 | -1.2 | 0.2 | -0.8 | |
| 4.5 | 4.1 | 8.0 | 7.1 | 9.0 | 5.7 | 11 | 14 | 7.3 | 8.6 | 10 | 11 | 37 | |
| 1.5 | 5.5 | 16 | -8.0 | -1.0 | 2.5 | -15 | 7.2 | -8.6 | 65 | 35 | -6.8 | 85 | |
| 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| -13 | 36 | -460 | -126 | 26 | 6.6 | 63 | 43 | 160 | 76 | 54 | 109 | 399 | |
| 0.0 | 1.7 | 0.0 | – | 0.0 | – | – | – | – | – | – | – | – | |
| -0.1 | 0.2 | 606 | 2.9 | 2.5 | 1.0 | 0.3 | 0.5 | 0.5 | 75 | 12 | 24 | 111 | |
| -32 | 18 | 140 | -152 | 6.4 | -24 | 11 | -4.1 | 66 | 65 | -48 | 7.8 | 92 | |
| -20 | -18 | -6.1 | -29 | -22 | -31 | -52 | -47 | -94 | -85 | -114 | -125 | -418 |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: August 3, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.